TABLE 3.
Top five targets with potentially critical roles in SchB treatment of SARS-CoV-2_hepatitis.
| Gene abbreviation | Degree | Closeness centrality | Betweenness centrality |
|---|---|---|---|
| EGFR | 7.0 | 9.8 | 41.5 |
| HSP90AA1 | 7.0 | 10.0 | 64.2 |
| MAPK1 | 5.0 | 8.8 | 24.7 |
| CDK2 | 4.0 | 7.8 | 14.7 |
| ATM | 4.0 | 8.0 | 21.5 |